Scientists Warn Vitamin B12 Guidelines May Put Aging Brains at Risk
UCSF study finds older adults with 'normal' but lower B12 levels show signs of slower thinking and brain damage.
Current vitamin B12 guidelines may not provide adequate protection for aging brains, according to new research from UC San Francisco that found older adults with "normal" but relatively low levels of the vitamin showed signs of cognitive decline and brain damage. The study challenges existing health standards and suggests that minimum B12 thresholds may need revision to prevent neurological problems.
The research, published in Annals of Neurology, examined 231 healthy older adults with an average age of 71 who did not have dementia or mild cognitive impairment. Even though participants had average B12 levels of 414.8 pmol/L -- well above the U.S. minimum cutoff of 148 pmol/L -- those with lower levels within the normal range still showed measurable cognitive and brain changes.
Study participants with lower active B12 levels demonstrated slower processing speed on cognitive tests and delayed responses to visual stimuli, indicating reduced brain signaling efficiency. The effects became more pronounced with advancing age, suggesting that older adults may be particularly vulnerable to subtle B12 deficiency even when blood levels appear adequate by current standards.
MRI brain scans revealed additional concerning findings. Participants with lower active B12 had higher volumes of white matter lesions, which are areas of brain injury linked to cognitive decline, dementia risk, and stroke. White matter consists of nerve fibers that enable communication between different brain regions, making damage to these areas particularly significant for cognitive function.
Senior author Dr. Ari J. Green from UCSF's Departments of Neurology and Ophthalmology said the findings suggest current B12 guidelines may miss early functional changes in the nervous system. "Previous studies that defined healthy amounts of B12 may have missed subtle functional manifestations of high or low levels that can affect people without causing overt symptoms," Green explained. The researchers advocate for incorporating functional biomarkers into B12 deficiency definitions to enable earlier intervention and potentially prevent cognitive decline in older adults.
